Head-to-head comparison
Kina vs Trimi
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Kina is a menopause-care telehealth platform where GLP-1 is the weight-loss treatment, offered alongside HRT, peptide, and compounded options for menopause symptoms.
From $179/mo (lowest dose rung) sema · From $179/mo (lowest dose rung) tirz · Verified June 2026
Marked down on: Compounded medications are not FDA-approved — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
Desk Score
Both molecules on one membership at a keen flat price, shipped free to all 50 states.
$175/mo sema · $235/mo tirz · Verified August 2026
Marked down on: Compounded only — no brand-name Ozempic/Wegovy or Mounjaro/Zepbound
Trimi takes this head-to-head with the higher Desk Score, 88/100 (B+) against 65/100 (C) for Kina. Kina still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Kina
65/100
C
Trimi
88/100
B+
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Kina | Trimi |
|---|---|---|
| Semaglutide | From $179/molowest dose rung$179/mo (starting dose, plus a separate fee, compounded) | $175/mo$175/mo month-to-month · $99/mo only on a 12-month prepay ($1,188 in one charge) |
| Tirzepatide | From $179/molowest dose rung$179/mo (starting dose, compounded) | $235/mo$235/mo month-to-month · $125/mo only on a 12-month prepay ($1,500 in one charge) |
| Coverage | Not listed on Kina's site (checked June 2026) | All 50 states |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Injectable only |
| Best for | Women in menopause wanting GLP-1 weight care alongside HRT, from board-certified physicians. | Cost-first patients who want both molecules at the cheapest sticker price and don't need brand-name or oral routes. |
| Desk Score | 65/100C | 88/100B+ |
The verdict
Desk pick — TrimiTrimi takes this head-to-head with the higher Desk Score, 88/100 (B+) against 65/100 (C) for Kina. Kina still holds its ground where its strengths line up with yours.
Choose Kina if…
Women in menopause wanting GLP-1 weight care alongside HRT, from board-certified physicians.
From $179/mo (lowest dose rung) sema · From $179/mo (lowest dose rung) tirz
Choose Trimi if…
Cost-first patients who want both molecules at the cheapest sticker price and don't need brand-name or oral routes.
$175/mo sema · $235/mo tirz · All 50 states
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: Kina · Trimi.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- CoreAge Rx vs Kina
- CoreAge Rx vs Trimi
- Elara Health and Wellness vs Kina
- Trimi vs Vytora Health
- Cora Health vs Kina
- HealthRX vs Trimi
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.